Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
暂无分享,去创建一个
P. Courtiol | C. Maussion | N. Le Stang | J. Altmuller | S. Boyault | A. Gonzalez-Perez | N. López-Bigas | L. Alexandrov | M. Copin | S. Lantuejoul | J. Mazières | F. Damiola | C. Caux | L. Fernandez-Cuesta | J. Deleuze | M. Brevet | M. Foll | A. Di Genova | D. Damotte | M. Ardin | P. Hofman | R. Olaso | A. Ghantous | N. Alcala | L. Mangiante | G. Planchard | Nathalie Rousseau | A. Scherpereel | S. Lacomme | J. Vignaud | C. Girard | C. Sagan | V. Hofman | J. Mouroux | I. Rouquette | A. Khandekar | Arnaud Poret | V. Meyer | C. Cuenin | C. Voegele | Jaehee Kim | P. Nuernberg | H. Hernández-Vargas | A. Sexton-Oates | A. Ibáñez-Costa | F. Thivolet | M. Michallet | D. Jean | S. Tabone-Eglinger | S. Giusiano-Courcambeck | C. Cohen | Xiran Liu | A. G. Ilg | T. M. Delhomme | Justo P. Castaño | R. Blázquez-Encinas | Nicolas Girard | Azhar Khandekar | C. Perrin | V. D. De Montpreville | A. Boland-Augé | Colin Giacobi | Lorraine Soudade | E. N. Bergstrom | Justo P Castaño | F. Galateau-Salle | A. Ibáñez-Costa | N. Girard
[1] L. Fernandez-Cuesta,et al. A molecular phenotypic map of malignant pleural mesothelioma , 2022, bioRxiv.
[2] J. Pearson,et al. Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma , 2022, Genome medicine.
[3] Erik N. Bergstrom,et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA , 2022, Nature.
[4] C. Steele,et al. Signatures of copy number alterations in human cancer , 2021, Nature.
[5] C. Swanton,et al. Cancer evolution: Darwin and beyond , 2021, The EMBO journal.
[6] J. Ngeow,et al. Homologous recombination deficiency: cancer predispositions and treatment implications. , 2021, The oncologist.
[7] R. Kurzrock,et al. Missing the target in cancer therapy , 2021, Nature Cancer.
[8] A. Jager,et al. Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation , 2021, Cancers.
[9] P. Robson,et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. , 2021, Cancer cell.
[10] H. Pass,et al. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review , 2021, Precision cancer medicine.
[11] L. Fernandez-Cuesta,et al. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas , 2021, Virchows Archiv.
[12] Joshua D. Campbell,et al. Whole genome doubling confers unique genetic vulnerabilities on tumor cells , 2020, Nature.
[13] W. Curran,et al. YAP1 Expression in Small Cell Lung Cancer Defines a Distinct Subtype with T-cell Inflamed Phenotype. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] A. Gonzalez-Perez,et al. A compendium of mutational cancer driver genes , 2020, Nature Reviews Cancer.
[15] F. Hirsch,et al. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution , 2020, Molecular oncology.
[16] J. Marioni,et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data , 2020, Genome Biology.
[17] Angela E. Leek,et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution , 2020, Nature Genetics.
[18] U. Alon,et al. Tumour heterogeneity and the evolutionary trade-offs of cancer , 2020, Nature Reviews Cancer.
[19] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[20] S. Armato,et al. EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] Uri Alon,et al. Tumor diversity and the trade-off between universal cancer tasks , 2019, Nature Communications.
[22] N. Girard,et al. Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions , 2019, EBioMedicine.
[23] G. Wainrib,et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome , 2019, Nature Medicine.
[24] F. Galateau-Sallé,et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy , 2019, CA: a cancer journal for clinicians.
[25] Aurélie A G Gabriel,et al. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids , 2019, Nature Communications.
[26] N. Le Stang,et al. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma , 2019, Modern Pathology.
[27] J. Zucman‐Rossi,et al. Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications , 2019, Nature Communications.
[28] Sarah H. Johnson,et al. Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[29] Lisle E Mose,et al. Improved indel detection in DNA and RNA via realignment with ABRA2 , 2019, Bioinform..
[30] E. Gazzano,et al. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event , 2019, International journal of molecular sciences.
[31] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[32] C. Cole,et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers , 2018, Nature Reviews Cancer.
[33] J. Bressler,et al. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis , 2018, Translational oncology.
[34] Christopher T. Saunders,et al. Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.
[35] J. V. van Meerbeeck,et al. Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma , 2018, Familial Cancer.
[36] B. Taylor,et al. Genome doubling shapes the evolution and prognosis of advanced cancers , 2018, Nature Genetics.
[37] Peter J. Park,et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing , 2018, bioRxiv.
[38] H. Noushmehr,et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. , 2018, Neuro-oncology.
[39] Benjamin J. Raphael,et al. The evolutionary history of 2,658 cancers , 2017, Nature.
[40] Joel s. Brown,et al. Classifying the evolutionary and ecological features of neoplasms , 2017, Nature Reviews Cancer.
[41] D. Schrump,et al. Targeting the epigenome in malignant pleural mesothelioma. , 2017, Translational lung cancer research.
[42] Paolo Di Tommaso,et al. Nextflow enables reproducible computational workflows , 2017, Nature Biotechnology.
[43] Joachim Weischenfeldt,et al. SvABA: genome-wide detection of structural variants and indels by local assembly , 2018, Genome research.
[44] M. Zanetti. Chromosomal chaos silences immune surveillance , 2017, Science.
[45] F. Balloux,et al. Transient structural variations have strong effects on quantitative traits and reproductive isolation in fission yeast , 2016, Nature Communications.
[46] Peter A. Jones,et al. Epigenetic Determinants of Cancer. , 2016, Cold Spring Harbor perspectives in biology.
[47] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[48] Xiaoyu Chen,et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..
[49] S. Pastorino,et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma , 2016, Oncogene.
[50] N. Lazar,et al. The ASA Statement on p-Values: Context, Process, and Purpose , 2016 .
[51] Thomas D. Wu,et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations , 2016, Nature Genetics.
[52] F. Galateau-Sallé,et al. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[53] Jean-Philippe Vert,et al. Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype , 2015, Human Genomics.
[54] Edwin Cuppen,et al. Sambamba: fast processing of NGS alignment formats , 2015, Bioinform..
[55] P. Laird,et al. Association between molecular subtypes of colorectal cancer and patient survival. , 2015, Gastroenterology.
[56] T. Nakajima,et al. Identification of actionable mutations in malignant pleural mesothelioma. , 2014, Lung cancer.
[57] Asma Ahmed,et al. The ESAT-6 Protein of Mycobacterium tuberculosis Interacts with Beta-2-Microglobulin (β2M) Affecting Antigen Presentation Function of Macrophage , 2014, PLoS pathogens.
[58] N. Friedman,et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells , 2014, Nature.
[59] Ira M. Hall,et al. SAMBLASTER: fast duplicate marking and structural variant read extraction , 2014, Bioinform..
[60] Thomas Zichner,et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..
[61] A. Viale,et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.
[62] D. Reinberg,et al. The Polycomb complex PRC2 and its mark in life , 2011, Nature.
[63] Xiao Zhang,et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.
[64] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[65] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[66] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[67] David Pellman,et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.
[68] Robert M. May,et al. Ecological Strategies and Population Parameters , 1974, The American Naturalist.